Toward a Systematic Assessment of Sex Differences in Cystic Fibrosis

(1) Background: Cystic fibrosis (CF) is a disease with well-documented clinical differences between female and male patients. However, this gender gap is very poorly studied at the molecular level. (2) Methods: Expression differences in whole blood transcriptomics between female and male CF patients are analyzed in order to determine the pathways related to sex-biased genes and assess their potential influence on sex-specific effects in CF patients. (3) Results: We identify sex-biased genes in female and male CF patients and provide explanations for some sex-specific differences at the molecular level. (4) Conclusion: Genes in key pathways associated with CF are differentially expressed between sexes, and thus may account for the gender gap in morbidity and mortality in CF.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Journal of personalized medicine - 13(2023), 6 vom: 31. Mai

Sprache:

Englisch

Beteiligte Personen:

Gärtner, Christiane [VerfasserIn]
Fallmann, Jörg [VerfasserIn]
Stadler, Peter F [VerfasserIn]
Kaiser, Thorsten [VerfasserIn]
Berkemer, Sarah J [VerfasserIn]

Links:

Volltext

Themen:

CAMP signaling pathway
Cystic fibrosis
Differential gene expression
Estrogen signaling pathway
Gender gap
Journal Article
SABV
Sex bias

Anmerkungen:

Date Revised 01.07.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/jpm13060924

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM358752256